Superworth

Bausch & Lomb price to sales ratio BLCO

Market value divided by revenue over the last twelve months, since 2023.

Today, Nov 2, 2026
1.3×
4-year median
1.2×
Against its 4-year history
64th
percentile: 0 is its lowest day, 100 its highest
4-year range
0.8× to 1.9×
Peer median
3.3×

Bausch & Lomb's price to sales ratio is 1.3× as of Nov 2, 2026.

That is above its 4-year median of 1.2×, close to the middle of its last 4 years.

Over that time it ranged from 0.8× in May 2025 to 1.9× in Jul 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 3.3×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.3×1.0×1.3×
20251.2×0.8×1.3×
20241.4×1.1×1.6×
20231.5×1.3×1.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest Bausch & Lomb's size, closest first, today.

CompanyPrice to sales ratio
BLCOBausch & Lomb1.3×
MSAMSA Safety3.7×
HAEHaemonetics4.0×
MMSIMerit Medical Systems3.1×
VNTVontier1.6×
PODDInsulet3.5×
GMEDGlobus Medical3.4×
ALGNAlign Technology2.6×
BMIBadger Meter5.1×
COOCooper Companies2.8×
ICUIICU Medical1.9×
Peer median3.3×

Where Bausch & Lomb ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Bausch & Lomb

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.